Skip to main content
Revvity logo
Contact us
Revvity Sites Globally

Select your location.

*e-commerce not available for this region.

australia.webp Australia
austria.webp Austria
belgium.webp Belgium
brazil.webp Brazil *
canada.webp Canada
china.webp China *
denmark.webp Denmark
finland.webp Finland
france.webp France
germany.webp Germany
hong-kong.webp Hong Kong (China) *
india.webp India *
ireland.webp Ireland
italy.webp Italy
japan.webp Japan *
luxembourg.webp Luxembourg
mexico.webp Mexico *
netherlands.webp Netherlands
norway.webp Norway
philippines.webp Philippines *
republic of korea.webp Republic of Korea *
singapore.webp Singapore *
spain.webp Spain
sweden.webp Sweden
switzerland.webp Switzerland
thailand.webp Thailand *
uk.webp United Kingdom
usa.webp United States
Breadcrumb
...
  • ホーム
  • 40 Years. Millions of Beginnings.

Committed to giving families a healthier start

What does it take to build confidence in screening? To know that the result a family is waiting for has been handled with care at every step? That when a lab faces a challenge, they're not facing it alone? For 40 years, Revvity has been working to answer those questions; from developing one of the world's first newborn screening kits in Finland to supporting the largest programs in the world today.

We don't just supply the science. We're there for the people who depend on it.

Want to stay part of the journey? Subscribe to our Newborn Screening or Maternal Fetal Health newsletter.

Subscribe Request more information
40 Years. Millions of Beginnings.
  • Quick links
  • Our story
  • Our people
  • Impact
  • Innovation
  • Screening programs
  • Solutions
  • Products
  • Resources
  • Contact

Our mission

No woman should die whilst bringing a new life into the world. Every baby, every child deserves a healthy start in life.

This is the reason our scientists come to work, the reason our service engineers answer calls on weekends, and the reason we've spent 40 years making sure the science gets to the people who need it.

Video thumbnail
Our heritage in lab

Heritage

The Wallac story: Where it all began

In 1985, a small team of scientists at Wallac in Turku, Finland, set out to develop one of the world's first automated screening systems - the beginning of a legacy that would quietly change the lives of millions.

Today, Revvity's screening solutions are used across the globe. But the pioneering spirit of those early Wallac innovators still guides everything we do.

Our people

Meet the people behind the science

Together, they've shaped 40 years of screening innovation. In their own words, meet the leaders, the experts, and the innovators who have made Revvity's work in newborn and prenatal screening possible.

Hear from Anna Godenhjelm, VP & GM, Reproductive Health, on 40 years of progress and what's next.

Video thumbnail

Read the full interviews

blog hjort thumbnail

4 questions with Mikael Hjort

40 years of newborn and prenatal screening.

Learn more
Suvi

4 questions with Suvituuli Poikonen

40 years of newborn and prenatal screening.

Learn more

Real stories, real results

Behind every screening result is a family, a clinician, a lab, real people whose lives have been changed by the work we do. Hear from the families whose stories remind us why this work matters, and from the partners who've experienced Revvity's commitment firsthand.

Video thumbnail
Video thumbnail
Video thumbnail

40 years of screening innovation

Four decades of milestones, breakthroughs, and firsts. Explore the key moments that have shaped early detection and intervention as we know it today.

Newborn screening infographic
Download newborn screening infographic
Prenatal infographic
Download prenatal infographic

The scale of our reach. The depth of our impact.

33M

babies screened annually by Revvity screening systems

9M+

pregnancies screened for trisomies every year

115+

countries served by Revvity

Screening programs: reaching more families worldwide

Some of our most meaningful work has been supporting countries as they launch their very first newborn screening programs. From program design to ongoing partnership, Revvity has helped build screening programs from the ground up across the globe, so that more families, in more places, can benefit from early detection.

Our screening impact

ILL Global Map - 40 years of Newborn and Prenatal Screening

Supporting Sickle Cell screening in Uganda

Recognizing world sickle cell day 2026
Learn more

Experts from the field

Video thumbnail

Explore our solutions

Newborn-screening-category-512.jpg

新生児スクリーニング

新生児の障害をスクリーニングする場合、正しい結果を迅速に得ることが重要です。
Learn more | View products
maternal-card.jpg

出生前検査

スクリーニングは非常に効果的な予防医療であり、医療の専門家が、健康問題や死亡につながる可能性のある疾患を発症するリスクの高い妊婦を特定することができます。
Learn more
Conditions and diseases

Conditions and Diseases

Welcome to Revvity's Conditions and Diseases Information Center, a comprehensive educational platform designed to support laboratories, healthcare professionals, and patients seeking detailed clinical information about specific health conditions.

Learn more
全てを表示 View less

Featured products

QSight 225 MD
QSight 225 MD Screening Systems (IVD)
Part number: 2040-0030
View details
GSP Front View Image
GSP Instrument (IVD)
Part number: 2021-0010
View details
SuperFlex Automated Immunoanalyzer
SuperFlex Automated Immunoassay Analyzer
Part number: SY36
View details
of 3

Featured resources

Awareness
Pre-eclampsia awareness
Learn more
Blog
Decades of innovation: Revvity's legacy in prenatal healthcare.
Learn more
Blog
Uniting for early detection: the role of Revvity in DMD screening.
Learn more
Blog
Recognizing world sickle cell day 2026: strengthening newborn screening capacity across sub-Saharan Africa.
Learn more
Blog
Building tomorrow - the professional journey of an SMA scientist.
Learn more
Blog
Advancing awareness: Revvity's dedication to rare disease & newborn screening.
Learn more

For in vitro diagnostic use. This product is only available where licensed in accordance with the law. Please contact your local representative for availability.

Revvity Inc. does not endorse or make recommendations with respect to research, medication, or treatments. All information presented is for informational purposes only and is not intended as medical advice. For country specific recommendations, please consult your local health care professionals.

line

Contact us

If you would like to speak to our experts, please click the button below to request more information.

Request more information
Request more information
Revvity Logo

©2026 Revvity - All rights reserved

Revvity is a trademark of Revvity, Inc. All other trademarks are the property of their respective owners.

Scroll Icon